WO2015088167A1 - 이소플라본 유도체 고함량 콩잎 또는 콩줄기, 및 그 제조 방법 - Google Patents
이소플라본 유도체 고함량 콩잎 또는 콩줄기, 및 그 제조 방법 Download PDFInfo
- Publication number
- WO2015088167A1 WO2015088167A1 PCT/KR2014/011493 KR2014011493W WO2015088167A1 WO 2015088167 A1 WO2015088167 A1 WO 2015088167A1 KR 2014011493 W KR2014011493 W KR 2014011493W WO 2015088167 A1 WO2015088167 A1 WO 2015088167A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- soybean
- extract
- leaves
- stems
- isoflavone
- Prior art date
Links
- 150000002515 isoflavone derivatives Chemical class 0.000 title claims abstract description 198
- 229930012930 isoflavone derivative Natural products 0.000 title claims abstract description 175
- 238000000034 method Methods 0.000 title claims abstract description 64
- 235000010627 Phaseolus vulgaris Nutrition 0.000 title abstract description 20
- 244000046052 Phaseolus vulgaris Species 0.000 title abstract description 20
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims abstract description 83
- 239000005977 Ethylene Substances 0.000 claims abstract description 83
- 201000010099 disease Diseases 0.000 claims abstract description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 25
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 15
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000005976 Ethephon Substances 0.000 claims abstract description 11
- 244000068988 Glycine max Species 0.000 claims description 519
- 235000010469 Glycine max Nutrition 0.000 claims description 504
- 239000000284 extract Substances 0.000 claims description 185
- 239000000203 mixture Substances 0.000 claims description 36
- -1 ethylene, ethylene Chemical group 0.000 claims description 30
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 30
- 235000008696 isoflavones Nutrition 0.000 claims description 30
- 238000004519 manufacturing process Methods 0.000 claims description 29
- 239000004480 active ingredient Substances 0.000 claims description 22
- 235000013402 health food Nutrition 0.000 claims description 20
- 206010030247 Oestrogen deficiency Diseases 0.000 claims description 19
- 239000008194 pharmaceutical composition Substances 0.000 claims description 18
- 239000003963 antioxidant agent Substances 0.000 claims description 14
- 235000006708 antioxidants Nutrition 0.000 claims description 14
- 238000009331 sowing Methods 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 13
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 10
- 230000002265 prevention Effects 0.000 claims description 10
- 208000001132 Osteoporosis Diseases 0.000 claims description 5
- 230000006872 improvement Effects 0.000 claims description 5
- 206010006187 Breast cancer Diseases 0.000 claims description 4
- 208000026310 Breast neoplasm Diseases 0.000 claims description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 4
- 208000019622 heart disease Diseases 0.000 claims description 4
- 230000009759 skin aging Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 208000027709 Vulvovaginal disease Diseases 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- AUFGMNSLVULYPF-BTVCFUMJSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal propanedioic acid Chemical compound OC(=O)CC(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O AUFGMNSLVULYPF-BTVCFUMJSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 206010016825 Flushing Diseases 0.000 claims 2
- 244000269722 Thea sinensis Species 0.000 claims 1
- 239000000262 estrogen Substances 0.000 abstract description 5
- 229940011871 estrogen Drugs 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 2
- 235000013376 functional food Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 58
- 238000002360 preparation method Methods 0.000 description 32
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 15
- 238000010586 diagram Methods 0.000 description 14
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 13
- 238000001035 drying Methods 0.000 description 13
- 125000000346 malonyl group Chemical group C(CC(=O)*)(=O)* 0.000 description 13
- 235000013616 tea Nutrition 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 241001122767 Theaceae Species 0.000 description 11
- 102000006995 beta-Glucosidase Human genes 0.000 description 11
- 108010047754 beta-Glucosidase Proteins 0.000 description 11
- 238000000605 extraction Methods 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- 238000003306 harvesting Methods 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 10
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempherol Natural products C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 9
- FRAUJUKWSKMNJY-RSEYPYQYSA-N malonylgenistin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 FRAUJUKWSKMNJY-RSEYPYQYSA-N 0.000 description 9
- FRAUJUKWSKMNJY-UHFFFAOYSA-N 5-hydroxy-3-(4-hydroxyphenyl)-7-(6-malonyl-beta-D-glucopyranosyloxy)-4H-1-benzopyran-4-one Natural products OC1C(O)C(O)C(COC(=O)CC(O)=O)OC1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 FRAUJUKWSKMNJY-UHFFFAOYSA-N 0.000 description 8
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 8
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 8
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 229930182470 glycoside Natural products 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 238000004949 mass spectrometry Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 235000006539 genistein Nutrition 0.000 description 6
- 229940045109 genistein Drugs 0.000 description 6
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 238000004445 quantitative analysis Methods 0.000 description 6
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 5
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 5
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 5
- 150000002338 glycosides Chemical class 0.000 description 5
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 5
- 235000008777 kaempferol Nutrition 0.000 description 5
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 5
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 5
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 235000019764 Soybean Meal Nutrition 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000007240 daidzein Nutrition 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- MTXMHWSVSZKYBT-UHFFFAOYSA-N malonyl daidzin Natural products OC1C(O)C(O)C(COC(=O)CC(O)=O)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 MTXMHWSVSZKYBT-UHFFFAOYSA-N 0.000 description 4
- MTXMHWSVSZKYBT-ASDZUOGYSA-N malonyldaidzin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 MTXMHWSVSZKYBT-ASDZUOGYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 239000004455 soybean meal Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000002031 ethanolic fraction Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 229960003415 propylparaben Drugs 0.000 description 3
- 229940075554 sorbate Drugs 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 235000019493 Macadamia oil Nutrition 0.000 description 2
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000010633 broth Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- DKQVJMREABFYNT-UHFFFAOYSA-N ethene Chemical compound C=C.C=C DKQVJMREABFYNT-UHFFFAOYSA-N 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000010469 macadamia oil Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000020712 soy bean extract Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000210756 Polyctenium Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000015724 Trifolium pratense Nutrition 0.000 description 1
- 239000000061 acid fraction Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000002036 chloroform fraction Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- CJYQQUPRURWLOW-YDLUHMIOSA-M dmsc Chemical compound [Na+].OP(=O)=O.OP(=O)=O.OP(=O)=O.[O-]P(=O)=O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O CJYQQUPRURWLOW-YDLUHMIOSA-M 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 235000020542 functional tea Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical class CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002661 non steroidal estrogen Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 235000013526 red clover Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 150000008136 β-glycosides Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
- A01N57/20—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds containing acyclic or cycloaliphatic radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Definitions
- Isoflavone derivative high content soybean leaf or soybean stem and its manufacturing method
- the present invention provides a method for producing isoflavone derivative high content soybean leaf or soybean stem, isoflavone derivative high content soybean leaf or soybean stem produced by the above method, uses of the isoflavone derivative high content soybean leaf or soybean meal, and soybean leaf or soybean meal A method for mass production of isoflavone derivatives.
- Isoflavone derivatives are representative of flavonoids with excellent pharmacological efficacy, and a lot of capital is being invested in the development of functional plants with high content worldwide.
- Isoflavones are nonsteroidal estrogens and are called phytoestrogens because they are chemically structural and physiologically similar to estrogens. They are similar to the female hormone estrogen and show useful physiological activity expected from estrogen. In particular, it has been reported to reduce the risk of osteoporosis occurring after menopause and to lower plasma cholesterol. It has also been reported to be effective in lowering the risk of coronary heart di sease and its antioxidant activity.
- Isoflavones exist in the form of glycosides linked to beta-glycosides or in the form of nonglycosides in which sugars have been separated.
- Non-glycosides include geni stein, daidzein and glycidine, and glycosides include geni st in, daidzin and glycidin. t in), etc.
- Soybean-derived non-fermented foods contain a large number of glycosides, while fermented foods contain mainly non-glycosides as sugars are degraded from glycosides by bacteria related to fermentation. Most isoflavones used in food and pharmaceuticals are extracted from soybeans and red clover.
- Korean Patent Laid-Open Publication No. 2003-93025 discloses a method for producing a high-density isoflavone-containing germinated soybean, in which the washed soybeans are soaked in purified water and then germinated to increase the isoflavone content by 40-70%. The disadvantage is that the content is low. On the other hand, soybean leaves have been reported to contain a very small amount of isopulabon derivatives.
- Another object of the present invention is isoflavone derivative high content soybean leaves or soybean stem, soybean leaves. Or it provides an extract of soybean stem, or food and pharmaceutical materials comprising a fraction of the extract.
- the present invention is a soybean leaf or soybean leaf containing a high content of isoflavone derivatives represented by the following [Formula 1] comprising the step of treating ethylene (ethylene), ethylene donor or ethylene generator To provide a method for producing soybean stem;
- Ri is independently H or 0H
- 3 ⁇ 4 is independently H, glucose (glucose) or glucose malonate.
- the present invention is isoflavone derivatives prepared by the above method Provides high content of soybean leaves or soybean stems.
- the present invention also provides a composition comprising a high content of isoflavone derivative soybean leaf or soybean stem, extract of the soybean leaf or soybean stem, or a fraction of the extract according to the present invention.
- the present invention is a pharmaceutical for the prevention and treatment of diseases caused by estrogen deficiency containing isoflavone derivative high content of soybean leaf or soybean stem, extract of the soybean leaf or soybean stem, or fraction of the extract as an active ingredient.
- the present invention is a health for the prevention and improvement of diseases caused by deficiency of estrogen containing isoflavone derivative high content soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract as an active ingredient according to the present invention Provide food.
- the present invention provides a pharmaceutical composition for antioxidant containing a high content of isopulabon derivatives soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract according to the present invention.
- the present invention provides a health food for antioxidant containing an isoflavone derivative high content soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract according to the present invention as an active ingredient.
- the present invention provides a skin care pharmaceutical composition containing an isoflavone derivative high content of soybean leaf or soybean stem, extract of the soybean leaf or soybean stem, or a fraction of the extract as an active ingredient.
- the present invention provides a cosmetic composition for skin care containing a high content of isoflavone derivative soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract according to the present invention as an active ingredient.
- the present invention provides a skin care health food containing a high content of isoflavone derivative soybean leaf or soybean stem, extract of the soybean leaf or soybean stem, or a fraction of the extract according to the present invention as an active ingredient.
- the present invention provides a tea (Tea) using isoflavone derivatives high content soybean leaves or soybean stem according to the present invention.
- the present invention provides a method for producing tea using a high content of isoflavone derivative soybean leaves or soybean stem according to the present invention.
- the present invention relates to ethylene, an ethylene donor or ethylene
- ethylene Provided is a method for mass production of isoflavone derivatives from soybean leaves or soybean stems using a generator.
- the present invention confirms that isoflavone derivatives accumulate at high concentrations in soybean leaves or soybean stems when treating ethylene or ethylene donor esepone in soybean plants 10-90 days after sowing.
- Soybean leaf or soybean stem containing soy isoflavone derivatives, extracts and extract fractions of soybean leaf or soybean stem containing high content of isoflavone derivatives, as well as methods for producing soybean leaf or soybean stem It can be usefully used.
- FIG. 1 is a diagram showing the content of the increase in content of isoflavone derivatives according to the cultivation period after the treatment of ethephon on the soybean leaves in UPLC chromatogram.
- Figure 2 is a diagram showing the UPLC chromatogram results of the extract extracted with soybean leaves before ethanol treatment with ethanol.
- Figure 3 is a diagram showing the UPLC chromatogram results of the extract extracted with ethanol soybean leaves after 7 days of the treatment of epone.
- FIG. 4 is a diagram showing the results of mass spectrometry (Q-TOF MS) in which peak 1 of FIG. 3 was found to be diidzin.
- FIG. 5 is a diagram showing the results of mass spectrometry (Q-TOF MS) in which peak 2 in FIG. 3 is genist in.
- FIG. 6 is a diagram showing the results of mass spectrometry (Q-TOF MS) in which peak 3 of FIG. 3 is malonyldaidzin.
- FIG. 7 is a diagram showing the results of mass spectrometry (Q-TOF MS) in which peak 4 of FIG. 3 is malonylgeni st in.
- FIG. 7 is a diagram showing the results of mass spectrometry (Q-TOF MS) in which peak 4 of FIG. 3 is malonylgeni st in.
- FIG. 8 is a diagram showing UPLC chromatogram results of extracts treated with beta-glucosidase ( ⁇ -ghicosidase) in extracts obtained by ethanol extraction of soybean leaves after 7 days of esepon treatment.
- FIG. 9 is a diagram showing the increase in content of isoflavone derivatives before and after treatment with ethylene (ethylene) in soybean stem by HPLC chromatogram.
- Fig. 11 shows the HPLC chromatogram result of the extract which extracted the soybean stem after ethylene treatment with ethane.
- FIG. 12 is a diagram showing the results of mass spectrometry (Q-TOF MS) in which peak 1 of FIG. 11 was found to be daidzin.
- FIG. 13 is a diagram showing a mass spectrometry (Q-TOF MS) result of identifying peak 2 of FIG. 11 is geni st in.
- FIG. 14 is a diagram showing the results of mass spectrometry (Q-TOF MS) identifying peak 3 of FIG. 11 as malonyldaidzin.
- FIG. 15 is a diagram showing the results of mass spectrometry (Q-TOF MS), in which peak 4 of FIG. 11 is malonylgeni st in.
- FIG. 15 is a diagram showing the results of mass spectrometry (Q-TOF MS), in which peak 4 of FIG. 11 is malonylgeni st in.
- FIG. 16 is a diagram showing UPLC chromatogram results of extracts treated with beta-glucosidase in extracts obtained by ethanol treatment of soybean stem after ethylene treatment.
- the present invention provides a method for producing an isoflavone derivative high content soybean leaf or soybean stem, comprising the step of treating ethylene (ethylene), an ethylene donor or an ethylene generator in the soybean leaf or soybean stem.
- the soybean leaves or soybean stem is preferably a soybean leaf or soybean stem or soybean stem that has elapsed 10 days or more after sowing, more preferably, soybean leaf or soybean stem 40 days after sowing is not limited thereto.
- the ethylene donor is preferably but not limited to ethephon.
- the ethylene is the simplest of the olefinic hydrocarbons (C 2 H 4 ), which is colorless and sweet gas. As a type of plant hormone, it has a function of promoting the maturation of plant tissues such as physiological changes after harvesting of fruits and vegetables, in particular, maturation of horticultural crops and yellowing of leafy vegetables.
- the above-mentioned esephon ethephon, 2-chloroethylphosphoni c acid
- esephon is a kind of ethylene generating agent, generates ethylene under neutral and alkaline conditions of pH 4. 1 or more, 100-2000 times aqueous solution in the liquid phase. When sprayed on fruits, it decomposes and generates ethylene to promote maturation, lodging and coloring.
- the ethylene, ethylene donor or ethylene generating agent is preferably treated at a concentration of 5 to 500 ppm, more preferably at a concentration of 5 to 100 ppm, but is not limited thereto.
- the ethylene, ethylene donor or ethylene generator can be treated before or after harvesting soybean leaves or soybean stem.
- the isoflavone derivative is preferably a compound represented by the following [Formula 1], and more preferably any one of the compounds represented by the following [Formula 2] to [Formula group], but is not limited to the word.
- the present invention provides a high soybean leaf or soybean stem isoflavone derivative prepared by the above production method.
- the isoflavone derivative is preferably a compound represented by the above [Formula 1], and more preferably any one of the compounds represented by the above [Formula 2] to [Formula group], but is not limited thereto.
- the present inventors treated soybean plants (5- 100 ppm) diluted in water with 40 days (growing time R4) soybean plants after sowing, isoflavones from 1 day after treatment Derivatives were found to increase significantly, reaching a maximum around 5-12 days after treatment (see FIG. 1).
- the camphor-peptide was a kaempferol glycoside, kaempferol-3- ⁇ - ⁇ -D-glucopyranosyl (1 ⁇ 2)- ⁇ — ⁇ rhamnopyranosyl (1 ⁇ 6) ⁇ ⁇ —D ⁇ ga 1 ac t opyr ano s ide,
- the extract obtained by extracting the ethanol from the soybeans treated with the essence and extracts obtained by separating beta-glucosidase ( ⁇ -glucosidase) to the extract and the soybean leaf extract 6 kinds of isoflavones Derivatives, dydazine, zenithine, malonyl dydazine, malonyl zenithine, daidzein and geni stein were obtained (see FIGS. 3-8).
- the present inventors have quantitatively analyzed four kinds of isoflavone derivatives, dydazine, genistin, malonyl didazine, and malonyl genistin, which are separated from the soybean leaves harvested after the essence treatment and the soybean leaves after the essence treatment.
- the content of isoflavone derivatives was remarkably increased in the case of the soybean leaves harvested after the treatment with ezephon, and the content of the isoflavone derivatives was also increased significantly in the case of the soybean leaves treated with esepon after harvesting.
- the present inventors treated ethylene (100-1000 ppm) in soybean plants 40 days after sowing (growing season R4), it was confirmed that the isoflavone derivatives significantly increased in soybean stem after treatment (Fig. 9). In addition, the isoflavone derivative was not detected in the soybean stem which was not treated with ethylene. However, in the ethylene-treated soybean stems, it was confirmed that four isoflavone derivatives, daidzin, zenistin, malonldaidzin, and malonyl zenistin, accumulated rapidly in soybean stem (see Table 3). .
- the ethylene-treated soybean stem was extracted with ethanol to obtain an extract, and the soybean stem extract was purified by extracting beta-glucosidase ( ⁇ -glucosidase) -extracted six kinds of isoflavone derivatives, Idzin, Zenithin, Malonyl Didezin, Malonyl genistin, daidzein and geni stein were obtained (see FIGS. 11-16).
- beta-glucosidase ⁇ -glucosidase
- the present inventors have quantitatively analyzed four kinds of isoflavone derivatives, didazine, genistin, malonyl didazine and malonyl genistin, which are separated from the soybean stems harvested after ethylene treatment and the ethylene treated soybean post harvest.
- isoflavone derivatives are significantly increased in the case of soybean stem harvested after ethylene treatment, so that the method of harvesting after treating ethylene in soybean stem isoflavone derivative high soybean stem production
- the method was confirmed to be possible (see Table 2).
- the present invention also provides a method for producing a large amount of isoflavone derivatives from soybean leaves or soybean stems using ethylene ethylene donors or ethylene generators.
- the soybean leaves or bean sprouts of step 1) is preferably a soybean leaf or soybean stem that has elapsed 10 days or more after sowing, more preferably a soybean leaf or soybean stem that has elapsed 40 days after sowing, and 10 to 90 after sowing Most preferably, the older comb leaf or soybean stem is preferred.
- the ethylene, ethylene donor or ethylene generator of step 1) can be treated before or after harvesting the soybean leaves.
- the ethylene donor of step 1) is preferably ethephon, but is not limited thereto, and any substance which induces or generates ethylene may be used.
- the ethylene, ethylene donor or ethylene of step 1) The generator is preferably treated at a concentration of 5 to 1000 ppm, more preferably at a concentration of 5 to 500 ppm, and even more preferably at a concentration of 5 to 100 ppm.
- the isoflavone derivative is preferably a compound represented by the above [Formula 1], more preferably any one or more of the compounds represented by the above [Formula 2] to [Formula group].
- the present invention treats ethylene and ethylene donor esepone to soybean leaves or soybean stem to produce soybean leaf or soybean stem containing high isoflavone derivatives, and the preparation method can be usefully used as a mass production method of isoflavone derivatives.
- the method of harvesting soybean front or soybean stem after the treatment of esepon, and the method of harvesting soybean leaf or soybean stem to treat the esepon confirms that the content of isoflavone derivatives is remarkably increased.
- a method of preparing soybean leaves or soybean stems containing high isoflavone derivatives by treating ethylene and ethylene donors after harvesting soybean leaves or soybean stems may be usefully used as a mass production method of isoflavone derivatives.
- the present invention comprises a soybean leaf or soybean stem isoflavone derivatives prepared by treating ethylene, ethylene donor or ethylene generator in a soybean leaf or soybean stem, soybean stem or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract To provide a composition.
- soybean leaf or soybean stem extract or fractions thereof is preferably prepared by a manufacturing method comprising the following steps:
- step 2) concentrating the filtered extract of step 2) under reduced pressure and drying to prepare a bean leaf or soybean stem extract
- the soybean leaf or soybean stem of step 1) is collected from a soybean plant in which isoflavone is accumulated at a high concentration after ethylene or esepone treatment.
- the ethylene or esepon treatment may be possible even after collecting the plant, but it is more preferable to treat the sample before collecting.
- the soybean plants treated with ethylene or esepone may be used as leaves, stems or roots, but are not limited thereto. According to a preferred embodiment of the present invention, it is preferable to use soybean leaves or soybean stems.
- the extraction solvent of step 1) is preferably water, alcohol or a combination thereof.
- the extraction solvent is preferably extracted by adding 1 to 10 times the amount of dried soybean leaves or bean stems, and more preferably 4 to 6 times to extract the extractant. Extraction degree is preferably 20 ° C to 100 ° C, more preferably 20 ° C to 40 ° C, most preferably, but not limited to.
- the extraction time is preferably 10 to 48 hours, more preferably 15 to 30 hours, most preferably 24 hours, but is not limited thereto.
- the number of extraction is preferably 1 to 5 times, more preferably 3 to 4 repeated extraction, and most preferably 3 times, but is not limited thereto.
- the decompression concentration in step 3) preferably uses a vacuum decompression concentrator or a vacuum rotary evaporator, but is not limited thereto.
- the drying is preferably reduced pressure drying, vacuum drying, boiling drying, spray drying or freeze drying, but is not limited thereto.
- the soybean 3 ⁇ 4 or soybean stem extract of step 4) is preferably a brown brown crude extract, which is a concentrated soybean stem extract, but is not limited thereto.
- the organic solvent may be n-nucleic acid, chloroform, ethyl acetate, or the like. It is preferably butanol, and according to a preferred embodiment of the present invention it is chloroform More preferred but not limited thereto.
- the fractions are n-nucleic acid fractions, chloroform fractions, ethyl acetate fractions, butanol fractions or water obtained by suspending soybean leaf or soybean stem extracts in water and then sequentially dividing the mixture into n-nucleic acid, chloroform , ethyl acetate, butanol and water. It is preferably a fraction, but is not limited thereto.
- the fraction may be obtained by repeating the fractionation process 1 to 5 times, preferably 3 times from the soybean leaf or soybean stem extract, and preferably concentrated under reduced pressure after the fraction, but is not limited thereto.
- the present invention is a soybean leaf or soybean stem isoflavone derivatives prepared by treating ethylene, ethylene donor or ethylene generator in the soybean leaf or soybean stem, the extract of the soybean leaf or soybean, or the fraction of the extract as an active ingredient It provides a pharmaceutical composition for the prevention and treatment of diseases caused by containing estrogen deficiency.
- the disease caused by the estrogen deficiency is preferably any one selected from the group consisting of osteoporosis, heart disease, breast cancer, vulva disease, hyperlipidemia, skin aging and facial relief.
- Isopolbon derivatives isolated from soybean leaf or soybean stem of the present invention have a physiological activity, so the soybean leaf or soybean extract containing the above compounds and fractions thereof are prevented and treated for diseases caused by estrogen deficiency. It can be usefully used as a pharmaceutical composition for.
- the composition of the present invention may further comprise suitable carriers, excipients and diluents commonly used in the manufacture of pharmaceutical compositions.
- composition of the present invention can be administered orally or parenterally, it is preferable to select the external or intraperitoneal injection, rectal injection, intradermal injection, intravenous injection, intramuscular injection or intrathoracic injection injection method when parenteral administration. It is not limited thereto.
- composition of the present invention powders, granules, tablets, It may be used in the form of oral dosage forms such as capsules, suspensions, emulsions, syrups, aerosols, external preparations, suppositories, and sterile injectable solutions.
- Carriers, excipients and diluents that may be included in the composition include lactose, dextrose, sucrose, sorbbi, manny, xili, erysri, malty, starch, acacia rubber, alginate, gelatin, calcium phosphate.
- Calcium silicate cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyridone, water, methyl hydroxy benzoate, propyl hydroxy benzoate, talc, magnesium stearate and mineral oil.
- diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents and surfactants are usually used.
- Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and these solid preparations may be used in combination medicines with at least one excipient such as starch, calcium carbonate, sucrose ( sucrose) or lactose, gelatin, etc.
- Oral liquid preparations include suspensions, solutions, emulsions, syrups, etc.
- simple diluents such as water and liquid paraffin
- various excipients such as wetting agents, sweeteners, fragrances, and preservatives may be included.
- Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations and suppositories.
- non-aqueous solvent suspending agent propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like can be used.
- a base of the suppository wi tepsol, macrogol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.
- Preferred dosages of the compositions of the present invention vary depending on the condition and weight of the patient, the extent of the disease, the form of the drug, the route of administration and the duration, and may be appropriately selected by those skilled in the art.
- the composition is preferably administered at 0.0001 to 1 g / kg, preferably 0.001 to 200 mg / kg per day, but is not limited thereto.
- the administration may be administered once a day, or may be divided several times.
- the dosage is seen in any way It does not limit the scope of the invention.
- the present invention is a soybean leaf or soybean stem isoflavone derivatives prepared by treating ethylene, ethylene donor or ethylene generator in a soybean leaf or soybean stem, the extract of the soybean leaf or soybean, or a fraction of the extract as an active ingredient
- the disease caused by the estrogen deficiency is preferably any one selected from the group consisting of osteoporosis, heart disease, breast cancer, vulvovaginal disease, hyperlipidemia, skin aging and hot flashes, but is not limited thereto.
- soybean leaf or soybean stem extract containing the compounds and fractions thereof for preventing and improving diseases caused by estrogen deficiency It can be usefully used as a health food.
- the health food of the present invention can be added to the isoflavone derivative high content of soybean leaves or soybean meal, the extract of the soybean leaf or soybean stem, or the fraction of the extract as it is, or used with other food or food ingredients, according to a conventional method Can be used as appropriate.
- the kind of food there is no particular limitation on the kind of food.
- the foods include functional tea blends, meats, sausages, breads, biscuits, rice cakes, candies, snacks, sweets, pizzas, ramen noodles, dairy products including noodles, gums, ice creams, various soups, drinks, and alcohol.
- Beverages and vitamin complexes, etc. includes all of the health food in the usual sense.
- the health beverage composition may be added at a ratio of 0.02 to 5 g, preferably 0.3 to 1 g, based on 100 m.
- the amount may be below the above range, and the active ingredient may be used in an amount above the above range because there is no problem in terms of safety.
- the health functional beverage composition of the present invention is not particularly limited, except for containing the isoflavone derivative high content soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract as an essential ingredient in a proportion thereof.
- various flavors, natural carbohydrates, and the like may be included as additional ingredients.
- the above described natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And sugars such as polysaccharides, for example, conventional sugars such as dex Srin, cyclodextrin, and the like, and xylyl, sorbitol, and erythritol.
- natural flavoring agents tautin, stevia extract (e.g., Rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. .
- the food of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and intermediates (cheese, chocolate, etc.), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, and the like.
- the isoflavone derivative high content soybean leaf or soybean stem of the present invention, the extract of the soybean leaf or soybean stem, or the fraction of the extract may contain the flesh for the production of natural fruit juice and fruit juice beverage and vegetable beverage.
- the ratio of the additive is not so important but is generally selected from the range of 0 to about 20 parts by weight per 100 parts by weight of the isoflavone derivative high content soybean or soybean stem, extract of the soybean leaf or soybean stem, or fraction of the extract of the present invention. to be.
- the present invention is a soybean leaf or soybean stem isoflavone derivatives prepared by treating the ethylene, ethylene donor or ethylene generator in a soybean front or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract as an active ingredient It provides a pharmaceutical composition for antioxidant containing.
- the present invention is a soybean leaf or soybean stem isoflavone derivatives prepared by treating ethylene, ethylene donor or ethylene generator in a soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract as an active ingredient It provides an antioxidant health food containing.
- soybean leaf or soybean extract containing the above compounds and fractions thereof may be usefully used as an antioxidant composition.
- the present invention is a soybean leaf or soybean stem isoflavone derivatives prepared by treating ethylene, ethylene donor or ethylene generator in a soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract is an active ingredient It provides a pharmaceutical composition for skin care containing.
- the present invention is a soybean leaf or soybean stem isoflavone derivatives prepared by treating ethylene, ethylene donor or ethylene generator in a soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract as an active ingredient It provides a cosmetic composition for skin care containing.
- the present invention is soybean leaf or soybean stem isoflavone derivatives prepared by treating ethylene, ethylene donor or ethylene generator in a high content soybean leaf or soybean stem, It provides a skin care health food containing an extract of soybean leaves or soybean stem, or a fraction of the extract as an active ingredient.
- the cosmetic composition may include, but is not limited to, lotions, ointments, gels, creams, patches or sprays.
- Isoflavone Derivatives of the Invention In preparing a cosmetic composition containing a high content of soybean leaves or soybean stems, extracts of the soybean leaves or soybean stems, or fractions of the extracts, the isoflavone derivatives of the present invention are commonly used in the composition for external application to skin. High content of soybean leaves or soybean stem, the soybean leaf or soybean stem extract, or fractions of the extract may be added in 3 to 30 parts by weight, preferably 5 or 20 parts by weight.
- the cosmetic composition of the present invention contains a high content of isoflavone derivative soybean leaf or soybean stem, an extract of the soybean leaf or soybean stem, or a fraction of the extract in addition to fatty substances, organic solvents, solubilizers, thickening agents and gelling agents, softeners.
- Antioxidants suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, It may contain adjuvants commonly used in the field of dermatology, such as essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or any other ingredients commonly used in cosmetic compositions.
- the ingredients may also be introduced in amounts generally used in the field of dermatology.
- the present invention provides a tea (tea) using isoflavone derivative high content soybean leaf or soybean stem according to the present invention.
- the present invention is isoflavone derivative high content soybean leaves or Beanstalks, and herbaceous plants with flavors, provide a blending tea. Tea using the bean leaf or bean stem
- 3) may be prepared by a manufacturing method comprising the step of drying the roasted bean leaves or stems.
- the pulverization of step 1) is preferably crushed to 1 to 5 kPa using a crusher, but the size is not limited thereto.
- the roasting of step 2) is preferably roasted for 30 to 60 minutes at a temperature of 250 to 300 ° C. in the roasting machine, but the temperature and time are not limited thereto.
- the drying of step 3) may be dried using a natural drying or a dryer, preferably drying for 24 to 36 hours at a temperature of 30 to 50 ° C, but the temperature and time is not limited thereto. .
- the herbaceous plant is preferably at least one selected from the group consisting of chemomile, lemongrass, rosehip, lavender, peppermint, fennel, rosemary, jasmine, hibiscus, rose flower, apple fruit, strawberry fruit, lemon fruit and orange flower All herbs are available.
- the tea or mixed tea may be processed into a form selected from the group consisting of flavor tea, tea bags, instant teas and cans.
- the present invention is to prevent or treat a disease caused by estrogen deficiency comprising administering to the subject an isoflavone derivative high content of soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract to the subject Provide a method.
- the present invention provides an antioxidant method comprising administering to the subject an isoflavone derivative high content soybean leaf or soybean stem, an extract of the soybean leaf or soybean stem, or a fraction of the extract of the present invention.
- the present invention provides a skin care method comprising the step of administering the isoflavone derivative high content of soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract to an individual.
- the present invention is a high content of isoflavone derivative soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract for use as a pharmaceutical composition for the prevention and treatment of diseases caused by estrogen deficiency Offer ' should.
- the present invention provides a high content of isoflavone derivative soybean leaf or soybean stem, the extract of the soybean leaf or soybean stem, or a fraction of the extract for use as a health food for the prevention and improvement of diseases caused by estrogen deficiency. do.
- the present invention provides a high content of isoflavone derivative soybean leaves or soybeans, extracts of the soybean leaves or soybean stems, or fractions of the extract for use as an antioxidant pharmaceutical composition.
- the present invention also provides a high content of isoflavone derivative soybean leaf or soybean stem, extract of the soybean leaf or soybean stem, or a fraction of the extract for use as an antioxidant health food.
- the present invention is isoflavone derivative high content soybean leaf or soybean stem, extract of the soybean leaf or soybean stem of the present invention for use as a pharmaceutical composition for skin care, Or a fraction of the extract.
- the present invention also provides an isoflavone derivative high content soybean leaf or soybean stem of the present invention for use as a cosmetic composition for skin care, or an extract of the soybean leaf or soybean stem, or a fraction of the extract.
- the present invention also provides a high content of isoflavone derivative soybean or soybean stem, extract of the soybean leaf or soybean stem, or a fraction of the extract of the present invention for use as a skin care health food.
- the present invention also provides a isoflavone derivative high content soybean leaf or soybean stem, extract of the soybean leaf or soybean stem, or sesame extract of the present invention for use as tea.
- the present invention will be described in more detail with reference to Examples.
- Soybean seed (Glycine max) was cultivated by the Rural Development Administration and grown in soybean plants 10 to 90 days after sowing, ethephon (ethephon, 2-chloroethylphosphoni c ac id) at a concentration of 5-100 ppm. Or 5 ⁇ 500 ppm of ethylene was treated to prepare a high content of isoflavone derivative soybean leaves.
- the accumulation of isoflavones in the soybean leaves may vary depending on the concentration of treated esepone or ethylene and the growing season of the treated plant.
- soybean leaves began to accumulate rapidly from day 1 and 5 to 12 days after treatment, soybean leaves with the highest concentration of isoflavones were obtained.
- soybean leaves were harvested from soybean plants (10-90 days old) after sowing and treated with soybean leaves periodically treated with ezephon diluted to a level of 5-100 ppm. Soybean leaves with the highest concentration of isoflavone derivatives were obtained about 3-10 days after treatment. As a result, as shown in Figure 1, the concentration of the target isoflavone derivatives of the soybean leaves increased after treatment, and obtained soybean leaves accumulating the highest concentration of isoflavone derivatives after 5-12 days after treatment. In addition, it was confirmed that the soybean leaves gradually changed to yellow under the influence of ethylene, a plant aging hormone (FIG. 1).
- Soybean seed (Glycine max) was collected and cultivated in Rong Chong, soybean pi ant from 10 to 90 days after sowing, ethephon (ethephon, 2-chloroethylphosphonic acid) 100-1000 ppm of ethylene was treated to produce isoflavone derivative high content soybean stem.
- the accumulation of isoflavones in soybean stems may vary depending on the concentration of treated esepone or ethylene and the growing season of the plant.
- soybean plants were treated with soybean plants with ethylene at a concentration of 200 ppm periodically.
- the concentration of the target isoflavone derivative of the soybean stem increased after treatment.
- the soybean stem gradually changes to yellow under the influence of ethylene, a plant aging hormone (FIG. 9). Therefore, the content of the isoflavone derivatives after treatment with 100-1000 ppm of ethylene or di-estone which was distilled at 5 ppm 100 ppm level in soybean plants 10 to 90 days after sowing Accumulated soybean stem was obtained.
- Example ⁇ 1-1> After drying the soybean leaves obtained by the method described in Example ⁇ 1-1> and extracting the solvent extracted by drying the extracted soybean leaves 1 kg with 80% ethanol at room temperature for 7 days, 86 g of the extract was concentrated under reduced pressure. Got it. The dried soybean leaves were extracted with pure water at 40-100 ° C. The extracted solvent was concentrated under reduced pressure to obtain an extract in a yield of 10-17%.
- Example ⁇ 1-2> After the beans obtained by the method of Example ⁇ 1-2> were dried and extracted with 50-1003 ⁇ 4 alcohol at 20-10 CTC conditions for 3-10 days. The extracted solvent was concentrated under reduced pressure to obtain an extract in 8 ⁇ 15% yield.
- ethylene-treated soybean stem was extracted with ethanol as compared to the extract of ethanol-treated soybean stem before ethanol treatment. It was confirmed that the content of the isoflavone derivatives in the extract is significantly high (Figs. 10 and 11).
- Example ⁇ 2-1> Separation and purification of isoflavone derivatives from the isoflavone high content soybean leaf ethane obtained by the method described in Example ⁇ 2-1> was performed using MPLC Teledyne Isco Comb Flash Companion.
- the column material C18 silica gel (YMC, 50 ii m) was used, and the elution condition was a water / acetonitrile mixture solution, which was obtained by applying a gradient elution (gradi ent elut ion) in which the acetonitrile solvent was increased to an initial 0-90%. Isoflavone derivatives of each species were isolated.
- isoflavone derivative high content soybean leaf ethane obtained by the method described in Example ⁇ 2-1> above to separate and purify the isoflavone derivative from the extract treated with beta-glucosidase ( ⁇ -glucosidase) C18 silica gel chromatography was performed to separate the two isoflavone derivatives in which the four isoflavone glycosides were converted by beta glucosidase, respectively. Thus, a total of six isoflavone derivatives were isolated.
- Example ⁇ 2-2> Separation and purification of isoflavone derivatives from the extract of isoflavone high content soybean stem ethane obtained by the method described in Example ⁇ 2-2> was performed using MPLC Teledyne Isco Combi Flash Companion.
- the column material was C18 silica gel (YMC, 50 ⁇ ⁇ ), and the elution condition was water / acetonitrile mixture solution. Isoflavone derivatives were isolated.
- UPLC is a company of Waters (USA) .
- ACQUITY UPLCTM system was used, and the column used ODS-based BEH C18 (100 ⁇ 2.1 mm).
- the mobile phase used was water containing 0.1% acetic acid and acetonitrile containing 0.1% acetic acid, and gradient elution was applied in which the acetonitrile solvent was increased from 57% to 15% for 15 minutes.
- the flow rate was adjusted to 0.4 i / min, the amount of the injected extraction solution was 2 t, and the detection wavelength was analyzed at 254 nm.
- isoflavone compounds separated by the method described in ⁇ Example 3> were dissolved in methane to prepare a standard solution in the range of 1-100 iiglvA, followed by UPLC analysis, and a calibration curve was prepared from the peak area. .
- the isoflavone standards used in the analysis were four types of dydazine, genistin, malonyl didazine, and malonyl genistin, and all of them used high purity standards of 98% or more (Table 1).
- Example ⁇ 1-1> soybean leaves of 10-90 days old soybean plants after the seeding of Example ⁇ 1-1> were collected and treated with 50 ppm of concentration of ezefonol, and the four isoflavone compounds were prepared by the method described in Example ⁇ 3-1>. After separation, quantitative analysis was performed as above (Table 2).
- HPLC was used for Perkinelmer (USA) HPLC Series 200 system, column was used Zolbox Bonus-RP (150x4.6150) of 0DS series.
- the mobile phase used water containing 0.1% acetic acid and acetonitrile containing 0.1% acetic acid, and gradient elution was applied in which the acetonitrile solvent was increased from 95% to 95% for 85 minutes.
- the flow rate was adjusted to 1 m «/ min, the amount of extracted solution was 10, and the detection wavelength was analyzed at 254 nm.
- Example ⁇ 3-2> Four isoflavone compounds separated by the method described in Example ⁇ 3-2> were dissolved in methanol to prepare a standard solution in the range of 1-100 / g /, to be analyzed by HPLC and calibrated from the peak area.
- the isoflavone standards used in the analysis were four types of dydazine, genistin malonyl didazine, and malonyl genistin, and high purity standards of 98% or more were used (Table 3).
- Soybean leaf and soybean stem with high content of isoflavone derivatives of the present invention are Soybean leaf and soybean stem with high content of isoflavone derivatives of the present invention.
- Extracts thereof or fractions of extracts 0.01 g Lactose 1.5 g Talc 0.5 g The above ingredients were combined and packed in a blister to prepare a powder.
- Extract thereof or fraction of extract 0.1 g lactose 7.9 g crystalline salose 1.5 g magnesium stearate 0.5 g
- a tablet was prepared by a di rect tableting method.
- Soybean leaf and soybean stem with high content of isoflavone derivatives of the present invention are Soybean leaf and soybean stem with high content of isoflavone derivatives of the present invention.
- Extracts or fractions thereof Extracts 1 g Corn starch 5 g Carboxycellose 4, 9 g
- the powder is filled into hard capsules according to the conventional method for preparing capsules.
- To prepare a capsule ⁇ l-4> Preparation of the injection
- Soybean leaf and soybean stem with high content of isoflavone derivatives of the present invention are Soybean leaf and soybean stem with high content of isoflavone derivatives of the present invention.
- each component was added and dissolved in purified water, and lemon flavor was added in an appropriate amount, followed by mixing the above components. Then, purified water was added to adjust the total to 100, and then filled into a brown bottle to sterilize to prepare a liquid.
- purified water was added to adjust the total to 100, and then filled into a brown bottle to sterilize to prepare a liquid.
- Isoflavone derivatives of the present invention was mixed with a high soybean leaf and soybean stem, its extract or a fraction of the extract and herb plants having a flavor, a mixed tea was prepared.
- Isoflavone derivatives of the present invention high soybean leaf and soybean stem, 0.5 5.0 parts by weight of the extract or fractions of the extract is added to the flour, and the mixed mixture Using bread, cake. Cookies, crackers and noodles were prepared.
- Isoflavone derivatives of the present invention High content of soybean leaves and soybean stems, extracts thereof or fractions of extracts thereof were added to soups and broths to prepare meat products for health promotion, soups and broths of noodles.
- Isopolbon derivatives of the present invention high content soybean leaves and soybean stem, 10 parts by weight of the extract or fractions of the extract was added to the ground beef to prepare a ground beef for health promotion.
- Brown rice. Barley, rice, and yulmu were alphad by a known method, and then dried and roasted, and then ground to a powder having a particle size of 60 mesh.
- Black beans, black sesame seeds The perilla was also steamed and dried by a known method, and then powdered into a grinder having a particle size of 60 mesh.
- Isoflavone derivative high content of soybean leaves and soybean stem, extracts thereof or fractions of extracts were concentrated under reduced pressure in a vacuum concentrator and sprayed.
- the dried product obtained by drying with a hot air dryer was pulverized with a particle size of 60 mesh to obtain a dry powder.
- Cereals (30 parts by weight brown rice, 15 parts by weight, 20 parts by weight of barley) ,
- Seeds (7 parts by weight perilla, 8 parts by weight black beans, 7 parts by weight black sesame seeds),
- Isoflavone derivative high content soybean leaves and soybean stem extracts thereof or fractions of the extract (3 parts by weight) of the present invention
- Soybean leaf and soybean stem with high content of isoflavone derivatives of the present invention are Soybean leaf and soybean stem with high content of isoflavone derivatives of the present invention.
- the resulting solution is filtered and obtained in a sterilized container, sealed sterilization and stored in a steamed storage of the present invention For the preparation of healthy beverage compositions.
- composition ratio is a composition suitable for a preferred beverage in a preferred embodiment, the composition ratio may be arbitrarily modified according to regional and ethnic preferences such as demand hierarchy, demand country, use purpose.
- Extracts or fractions thereof Extract 3.5 parts by weight Setostearyl alcohol 1.6 parts by weight Stearic acid 1.4 parts by weight 4 lipophilic glycerol monostearate 1.8 parts by weight sebum-100 stearate 2.6 parts by weight sesquilane sorbate sorbate 0.6 parts by weight squalene 4.8 parts by weight macadamia oil
- Jojoba oil 2 parts by weight 0: 4 parts by weight of tocopeacetic acid 0.2 parts by weight of methyl polysiloxylic acid 0.1 parts by weight of ethylparaben 0.1 parts by weight of propylparaben
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201480075528.3A CN106028795B (zh) | 2013-12-13 | 2014-11-27 | 具有高含量异黄酮衍生物的豆叶或豆茎及其制备方法 |
JP2016539220A JP6364085B2 (ja) | 2013-12-13 | 2014-11-27 | イソフラボン誘導体含量の高い豆葉部又は豆茎部及びそれを作製する方法 |
EP14869566.1A EP3085226B1 (en) | 2013-12-13 | 2014-11-27 | Bean leaves or bean stems having high isoflavone derivative content, and method for preparing same |
US15/179,720 US10183050B2 (en) | 2013-12-13 | 2016-06-10 | Bean leaves or bean stems having high isoflavone derivatives content and method for preparing same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130155430A KR101451298B1 (ko) | 2013-12-13 | 2013-12-13 | 이소플라본 유도체 고함량 콩잎 및 그 제조방법 |
KR10-2013-0155430 | 2013-12-13 | ||
KR10-2014-0082481 | 2014-07-02 | ||
KR1020140082481A KR101607188B1 (ko) | 2014-07-02 | 2014-07-02 | 이소플라본 유도체 고함량 콩줄기 및 그 제조 방법 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/179,720 Continuation US10183050B2 (en) | 2013-12-13 | 2016-06-10 | Bean leaves or bean stems having high isoflavone derivatives content and method for preparing same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015088167A1 true WO2015088167A1 (ko) | 2015-06-18 |
Family
ID=53371425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2014/011493 WO2015088167A1 (ko) | 2013-12-13 | 2014-11-27 | 이소플라본 유도체 고함량 콩잎 또는 콩줄기, 및 그 제조 방법 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10183050B2 (ko) |
EP (1) | EP3085226B1 (ko) |
JP (1) | JP6364085B2 (ko) |
CN (1) | CN106028795B (ko) |
WO (1) | WO2015088167A1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110100739B (zh) * | 2019-06-24 | 2022-05-27 | 延边大学 | 一种促进黄芪不定根异黄酮积累的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030093025A (ko) | 2002-06-01 | 2003-12-06 | 고을빛 생식마을 (주) | 고농도 이소플라본이 함유된 발아콩의 제조방법 |
KR20050104097A (ko) * | 2004-04-28 | 2005-11-02 | 학교법인 건국대학교 | 이소플라본 강화 발아 콩 및 그 제조방법 |
KR100823611B1 (ko) * | 2005-09-07 | 2008-04-21 | 인하대학교 산학협력단 | 초음파를 이용한 콩에서 이소플라본의 추출 방법 및 그추출용 초음파 반응기 |
KR20110009402A (ko) * | 2009-07-22 | 2011-01-28 | 대한민국(관리부서:농촌진흥청장) | 콩 종자의 이소플라본 함량을 증가시키는 방법 |
KR20120136164A (ko) * | 2011-06-08 | 2012-12-18 | 강원대학교산학협력단 | 원적외선 조사를 이용한 이소플라본 함량이 증가된 대두분말의 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2183964C2 (ru) * | 1997-07-30 | 2002-06-27 | Индена С.П.А. | Экстракт сои, способ его приготовления и фармацевтическая композиция |
JP2000262244A (ja) * | 1999-03-18 | 2000-09-26 | Ajinomoto Co Inc | 大豆イソフラボン含有組成物とその製造方法 |
EP1359215B1 (en) * | 2002-04-30 | 2010-03-10 | Societe Des Produits Nestle S.A. | Use of a soya cell strains with high isoflavone content |
CN1711035A (zh) * | 2002-11-15 | 2005-12-21 | 嘉吉有限公司 | 可溶性异黄酮组合物 |
WO2005074710A1 (en) * | 2004-02-06 | 2005-08-18 | Konkuk University Industrial Coorperation Corp | Sprouted bean containing high concentration of isoflavone and the preparing method thereof |
KR100553522B1 (ko) * | 2004-02-06 | 2006-02-20 | 학교법인 건국대학교 | 이소플라본 강화 발아 녹두 및 그 제조방법 |
DE102004020712A1 (de) * | 2004-04-27 | 2005-11-24 | Beiersdorf Ag | Kosmetische Kapseln |
US7553505B2 (en) * | 2006-01-12 | 2009-06-30 | The Hong Kong University Of Science And Technology | Health care product containing isoflavone aglycones and method of producing the same |
CN101723926B (zh) * | 2008-10-10 | 2012-02-22 | 四川省中医药科学院 | 一种异黄酮衍生物及其制备方法和用途 |
CN101513484B (zh) * | 2009-03-17 | 2011-06-22 | 河北大学附属医院 | 一种预防和治疗骨质疏松的药物组合物及其制备方法 |
CN101974577A (zh) * | 2010-09-27 | 2011-02-16 | 徐州技源天然保健品有限公司 | 一种新型提取大豆异黄酮苷元的生产工艺 |
-
2014
- 2014-11-27 EP EP14869566.1A patent/EP3085226B1/en active Active
- 2014-11-27 CN CN201480075528.3A patent/CN106028795B/zh active Active
- 2014-11-27 WO PCT/KR2014/011493 patent/WO2015088167A1/ko active Application Filing
- 2014-11-27 JP JP2016539220A patent/JP6364085B2/ja active Active
-
2016
- 2016-06-10 US US15/179,720 patent/US10183050B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030093025A (ko) | 2002-06-01 | 2003-12-06 | 고을빛 생식마을 (주) | 고농도 이소플라본이 함유된 발아콩의 제조방법 |
KR20050104097A (ko) * | 2004-04-28 | 2005-11-02 | 학교법인 건국대학교 | 이소플라본 강화 발아 콩 및 그 제조방법 |
KR100823611B1 (ko) * | 2005-09-07 | 2008-04-21 | 인하대학교 산학협력단 | 초음파를 이용한 콩에서 이소플라본의 추출 방법 및 그추출용 초음파 반응기 |
KR20110009402A (ko) * | 2009-07-22 | 2011-01-28 | 대한민국(관리부서:농촌진흥청장) | 콩 종자의 이소플라본 함량을 증가시키는 방법 |
KR20120136164A (ko) * | 2011-06-08 | 2012-12-18 | 강원대학교산학협력단 | 원적외선 조사를 이용한 이소플라본 함량이 증가된 대두분말의 제조방법 |
Non-Patent Citations (3)
Title |
---|
BIOMEDICINE & PHARMACOTHERATY, vol. 56, 2002, pages 289 - 295 |
J. AGRIC. FOOD CEHM., vol. 60, 2012, pages 6045 - 6055 |
SHAILY GOYAL K. ET AL.: "ETHREL TREATMENT ENHANCED ISOFLAVONOIDS ACCUMULATION IN CELL SUSPENSION CULTURESOF PUERARIA TUBEROSA, A WOODY LEGUME", ACTA PHYSIOL PLANT, vol. 30, no. 6, 2008, pages 849 - 853, XP055288465 * |
Also Published As
Publication number | Publication date |
---|---|
EP3085226B1 (en) | 2020-09-09 |
US20160317597A1 (en) | 2016-11-03 |
CN106028795B (zh) | 2020-03-03 |
JP2017501700A (ja) | 2017-01-19 |
EP3085226A4 (en) | 2016-11-30 |
US10183050B2 (en) | 2019-01-22 |
JP6364085B2 (ja) | 2018-07-25 |
CN106028795A (zh) | 2016-10-12 |
EP3085226A1 (en) | 2016-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101174497B1 (ko) | 새싹보리 유래 폴리페놀계 화합물을 함유하는 추출물 및 이의 제조방법 | |
KR101451298B1 (ko) | 이소플라본 유도체 고함량 콩잎 및 그 제조방법 | |
KR101187032B1 (ko) | 벌개미취의 추출물, 분획물 또는 이로부터 분리한 짐나스테르코리아인 b 화합물을 유효성분으로 함유하는 간 보호 또는 개선용 조성물 | |
KR20210133171A (ko) | 달맞이꽃 추출물을 유효성분으로 포함하는 비만 또는 비만으로부터 유도된 대사증후군의 예방 또는 치료용 조성물 | |
KR101590842B1 (ko) | 고요산혈증 또는 통풍에 유효한 섬쑥부쟁이 추출물, 이의 분획물 및 이로부터 분리된 활성화합물 | |
KR20140133016A (ko) | 나한과(Siraitia grosvenorii) 추출물의 제조방법 및 이를 포함하는 조성물 | |
KR101075554B1 (ko) | 돌단풍 추출물 또는 이의 분획물을 유효성분으로 함유하는 폐경기 증후군 예방 및 치료용 조성물 | |
US10183050B2 (en) | Bean leaves or bean stems having high isoflavone derivatives content and method for preparing same | |
KR101607188B1 (ko) | 이소플라본 유도체 고함량 콩줄기 및 그 제조 방법 | |
KR101514284B1 (ko) | 땃두릅나무 추출물 또는 이의 분획물을 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물 | |
KR101971986B1 (ko) | 참나무겨우살이 추출물을 유효성분으로 포함하는 항암용 조성물 | |
KR102282625B1 (ko) | 암조건(dark condition)에서 이소플라본 유도체 고함량 콩잎의 제조방법 및 상기 방법으로 제조된 이소플라본 유도체 고함량 콩잎 | |
KR101925420B1 (ko) | 요산 배출용 디노익산 화합물 및 이의 유도체, 및 이를 포함하는 조성물 | |
KR100533283B1 (ko) | 혼합 생약재 추출물을 유효성분으로 하는 골다공증 예방및 치료용 조성물 | |
KR101651100B1 (ko) | 상백피에서 유래된 mac 6.4 비만 치료 또는 예방용 화합물 | |
KR102321579B1 (ko) | Kiom 법하수오 추출물을 유효성분으로 포함하는 골다공증의 예방, 개선 또는 치료용 조성물 | |
KR101712889B1 (ko) | 양하 추출물 및 이의 분획물을 유효성분으로 함유하는 퇴행성 뇌질환 예방 및 치료용 약학적 조성물 | |
KR100686362B1 (ko) | 청대추 추출물을 포함하는 비만의 치료 및 예방용 조성물 | |
KR101684432B1 (ko) | 카테치노세아노틱산 화합물 및 이를 포함하는 약학적 조성물 | |
KR20170091242A (ko) | 많첩빈도리 추출물을 함유하는 조성물 | |
KR101651105B1 (ko) | 상백피에서 유래된 mac 9.23 비만 치료 또는 예방용 화합물 | |
KR20230071796A (ko) | 스마트-대사체 챔버를 이용한 이소플라본 유도체가 증진된 콩 식물체 재배방법 | |
KR101651103B1 (ko) | 상백피에서 유래된 mac 9.24 비만 치료 또는 예방용 화합물 | |
KR20230072430A (ko) | 스마트-대사체 챔버를 이용한 진세노사이드 Rb1, Rb2 및 Rg2가 증진된 새싹인삼의 재배방법 | |
KR20180035769A (ko) | 많첩빈도리 추출물을 함유하는 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14869566 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016539220 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2014869566 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014869566 Country of ref document: EP |